IDEX Biometrics: IDEX Biometrics ASA: Resolution to carry out Tranche 2 of the Private Placement

Reference is made to the announcements by IDEX Biometrics ASA (the "Company") on 29 April 2026, regarding a private placement of 9,696,969 shares at NOK 8.25 per share in two tranches (the "Private Placement"). The Company's board of directors has today, pursuant to the existing board authorization granted by the Company's extraordinary general meeting on 27 March 2026, resolved to increase the Company's share capital in relation to the second tranche of the Private Placement, consisting of 3,295,773 shares at a subscription price of NOK 8.25 per share ("Tranche 2").

Following registration of the share capital increase pertaining to the Tranche 2 shares, the Company will have a share capital of NOK 74,808,932 divided into 74,808,932 shares, each with a nominal value of NOK 1 and each carrying one vote at the Company's general meeting.

Listing of the new shares pertaining to Tranche 2 requires approval and publication of a listing prospectus as approved by the Norwegian Financial Supervisory Authority. The shares pertaining to Tranche 2 will be issued on a separate, unlisted ISIN and will only become tradable on Euronext Oslo B¸rs following approval and publication of the prospectus, expected during Q2 2026.

For more information, please contact:Anders Storbr¥ten, CEO and CFOTel: +47 416 38 582E-mail: [email protected]

ABOUT IDEX BIOMETRICS ASAIDEX Biometrics ASA (OSE: IDEX) is a global technology leader in fingerprint biometrics, offering authentication solutions across payments, access control, and digital identity. Our solutions bring convenience, security, peace of mind and seamless user experiences to the world. Built on patented and proprietary sensor technologies, integrated circuit designs, and software, our biometric solutions target card-based applications for payments and digital authentication. As an industry-enabler we partner with leading card manufacturers and technology companies to bring our solutions to market.

The disclosures set out in this announcement are subject to the disclosure requirement pursuant to section 5-12 of the Norwegian Securities Trading Act.

AttachmentsIDEX Biometrics ASA: Resolution to carry out Tranche 2 of the Private Placement